New strategy may target common cancer driver with minimal side effects
Researchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it, in a study led by investigators at Weill Cornell Medicine. The findings suggest the possibility of a potent, low-side-effect treatment that could benefit many patients with colorectal, breast and other cancer types.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Exploring sex differences in how the brain adapts to overeating
Science
Biology
Global
-
Rapid genome sequencing helps guide care for about 50% of children with cancer
Science
Geology
South Africa
-
After adult-onset hearing loss, an adaptation in the brain may improve vision
Entertainment
TV
United States
-
Subtype-specific mutations drive relapse risk in most common childhood leukemia
Science
Research
-
Researchers identify connection between pulmonary hypertension and cognitive impairment
Health
Disease & Outbreaks
-
Surgeons take major step toward artificial vision
Science
Research
-
Children's e-bike injuries increase 33% per quarter as e-scooter injuries climb 15%
Health
Disease & Outbreaks
-
Simulated heart failure appointments uncover shared consultation patterns among doctors across four countries
Health
Medicine
Global